165 related articles for article (PubMed ID: 8587787)
1. Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice.
Waki S; Uehara S; Kanbe K; Nariuch H; Suzuki M
Parasite Immunol; 1995 Oct; 17(10):503-8. PubMed ID: 8587787
[TBL] [Abstract][Full Text] [Related]
2. A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection.
Yoneto T; Waki S; Takai T; Tagawa Yi ; Iwakura Y; Mizuguchi J; Nariuchi H; Yoshimoto T
J Immunol; 2001 May; 166(10):6236-41. PubMed ID: 11342646
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
[TBL] [Abstract][Full Text] [Related]
4. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical.
Yoneto T; Yoshimoto T; Wang CR; Takahama Y; Tsuji M; Waki S; Nariuchi H
Infect Immun; 1999 May; 67(5):2349-56. PubMed ID: 10225894
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.
Matsumoto S; Yukitake H; Kanbara H; Yamada H; Kitamura A; Yamada T
Vaccine; 2000 Nov; 19(7-8):779-87. PubMed ID: 11115699
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12-dependent mechanisms in the clearance of blood-stage murine malaria parasite Plasmodium berghei XAT, an attenuated variant of P. berghei NK65.
Yoshimoto T; Yoneto T; Waki S; Nariuchi H
J Infect Dis; 1998 Jun; 177(6):1674-81. PubMed ID: 9607848
[TBL] [Abstract][Full Text] [Related]
7. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice.
Su Z; Stevenson MM
J Immunol; 2002 Feb; 168(3):1348-55. PubMed ID: 11801675
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G2a isotype may have a protective role in Plasmodium berghei NK65 infection in immunised mice.
Akanmori BD; Waki S; Suzuki M
Parasitol Res; 1994; 80(8):638-41. PubMed ID: 7886031
[TBL] [Abstract][Full Text] [Related]
9. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice.
Dobber R; Tielemans M; Nagelkerken L
Cell Immunol; 1995 Feb; 160(2):185-92. PubMed ID: 7720078
[TBL] [Abstract][Full Text] [Related]
10. The spleen, IgG antibody subsets and immunity to Plasmodium berghei in rats.
Smith NC; Favila-Castillo L; Monroy-Ostria A; Hirunpetcharat C; Good MF
Immunol Cell Biol; 1997 Jun; 75(3):318-23. PubMed ID: 9243299
[TBL] [Abstract][Full Text] [Related]
11. A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice.
Bagai U; Pawar A
Parasitol Int; 2013 Jun; 62(3):329-36. PubMed ID: 23085043
[TBL] [Abstract][Full Text] [Related]
12. Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells.
D'Império Lima MR; Alvarez JM; Furtado GC; Kipnis TL; Coutinho A; Minóprio P
Scand J Immunol; 1996 Mar; 43(3):263-70. PubMed ID: 8602459
[TBL] [Abstract][Full Text] [Related]
13. The role of T cells in pathogenesis and protective immunity to murine malaria.
Waki S; Uehara S; Kanbe K; Ono K; Suzuki M; Nariuchi H
Immunology; 1992 Apr; 75(4):646-51. PubMed ID: 1350570
[TBL] [Abstract][Full Text] [Related]
14. The age-related resistance of rats to Plasmodium berghei infection is associated with differential cellular and humoral immune responses.
Adam E; Pierrot C; Lafitte S; Godin C; Saoudi A; Capron M; Khalife J
Int J Parasitol; 2003 Sep; 33(10):1067-78. PubMed ID: 13129529
[TBL] [Abstract][Full Text] [Related]
15. Flt3 ligand treatment modulates parasitemia during infection with rodent malaria parasites via MyD88- and IFN-γ-dependent mechanisms.
Tamura T; Akbari M; Kimura K; Kimura D; Yui K
Parasite Immunol; 2014 Feb; 36(2):87-99. PubMed ID: 24400637
[TBL] [Abstract][Full Text] [Related]
16. Antibody response in Plasmodium vinckei malaria after treatment with chloroquine and adjuvant interferon-gamma.
Finnemann S; Kremsner PG; Chaves MF; Schumacher C; Neifer S; Bienzle U
Parasitol Res; 1992; 78(8):629-34. PubMed ID: 1480597
[TBL] [Abstract][Full Text] [Related]
17. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated parasite clearance in mice infected with Plasmodium berghei following treatment with manzamine A.
Ang KK; Holmes MJ; Kara UA
Parasitol Res; 2001 Sep; 87(9):715-21. PubMed ID: 11570556
[TBL] [Abstract][Full Text] [Related]
19. Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.
Taylor PR; Seixas E; Walport MJ; Langhorne J; Botto M
Infect Immun; 2001 Jun; 69(6):3853-9. PubMed ID: 11349051
[TBL] [Abstract][Full Text] [Related]
20. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
